People: Developer Of Recombinant BCG Vaccine Wins Infectious Disease Research Award

Barry R. Bloom, an immunologist at the Albert Einstein College of Medicine in New York and an investigator with the Howard Hughes Medical Institute, last month received the first annual Bristol- Myers Squibb Award for Distinguished Achievement in Infectious Disease Research. The $50,000 cash prize was given in recognition of Bloom's contributions to immunology, including the development of an experimental recombinant multiple vaccine and investigations of leprosy and tuberculosis. Throughout

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Throughout most of his career, Bloom's research has focused on health problems in developing countries. But this was not always the case. "I started out revolted by applied science," recalls Bloom. "I was going to be the most basic" of basic researchers. He changed his mind about the value of applied research on a trip to India in 1968, where, he says, "I gained perspective on the world, and what my training in medical research could do."

One aspect of this focus is the development of a multipurpose vaccine created by genetically engineering the bacillus BCG (bacille Calmette-Gurin). BCG, used to protect against tuberculosis, is the oldest and most widely used vaccine in the world. Bloom's lab, along with collaborators at the University of Pittsburgh and MedImmune Inc. of Gaithersburg, Md., have developed a method of introducing protective antigens for a variety of diseases into BCG, so that this vaccine ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Rebecca Andrews

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio